3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 4
1
Phase 3
1
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoma
3
Leukemia, Myeloid, Acute
3
Leukemia
3
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Anemia, Refractory, with Excess of Blasts
2
Warts
1
Testicular Neoplasms
1
Testicular Germ Cell Tumor
1
Teratoma
1
Seminoma
1
Recurrence
1
Neutropenia
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Biphenotypic, Acute
1
Infections
1
Immunologic Deficiency Syndromes
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Graft vs Host Disease
1
Febrile Neutropenia
1
Endodermal Sinus Tumor
1
Carcinoma, Embryonal
1
Breast Neoplasms
1
Anemia, Refractory
1
Agammaglobulinemia
1
Interventions
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Febrile Neutropenia
×
Filgrastim
×
Clear all
NCT02427919
2015-04-28
DeGREE
Seoul St. Mary's Hospital
Phase 2/3
Unknown
56 enrolled